Anti-inflammatory Effects of Cavidine In Vitro and In Vivo, a Selective COX-2 Inhibitor in LPS-Induced Peritoneal Macrophages of Mouse

Inflammation

Volumn 38, Issue 2, 2015, Pages 923-933

  Niu, Xiaofeng ^a   Zhang, Hailin ^a   Li, Weifeng ^a   Mu, Qingli ^a   Yao, Huan ^a   Wang, Yu ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

cavidine; cyclooxygenase 2; inflammatory; nitric oxide; pro inflammatory cytokines

Indexed keywords

ACETIC ACID; ANTIINFLAMMATORY AGENT; CAVIDINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FORMALDEHYDE; INTERLEUKIN 6; ISOQUINOLINE ALKALOID; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XYLENE; BERBERINE DERIVATIVE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; EAR EDEMA; EXPERIMENTAL PERITONITIS; FEMALE; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PAW EDEMA; PERITONEUM MACROPHAGE; TREATMENT RESPONSE; ANIMAL; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BERBERINE ALKALOIDS; CELLS, CULTURED; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE;

EID: 84925497290     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0054-4     Document Type: Article

References (35)

1. Byeon, S.E., J.Y. Chung, Y.G. Lee, B.H. Kim, and K.H. Kim. 2008. In vitro and in vivo anti-inflammatory effects of taheebo, a water extract from the inner bark of Tabebuia avellanedae. Journal of Ethnopharmacology 119: 145–152.
2. Castardo, J.C., A.S. Prudente, J. Ferreira, C.L. Guimarães, F.D. Monache, M.F. Otuki, and D.A. Cabrini. 2008. Anti-inflammatory effects of hydroalcoholic extract and two biflavonoids from Garcinia gardneriana leaves in mouse paw oedema. Journal of Ethnopharmacology 118: 405–411.
3. Li, W., H. Huang, Y. Zhang, T. Fan, X. Liu, W. Xing, and X. Niu. 2013. Anti-inflammatory effect of tetrahydrocoptisine from Corydalis impatiens is a function of possible inhibition of TNF-α, IL-6 and NO production in lipopolysaccharide-stimulated peritoneal macrophages through inhibiting NF-κB activation and MAPK pathway. European Journal of Pharmacology 715: 62–71.
4. Serhan, C.N., and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nature Immunology 6: 1191–1197.
5. Shohami, E., I. Ginis, and J.M. Hallenbeck. 1999. Dual role of tumor necrosis factor alpha in brain injury. Cytokine & Growth Factor Reviews 10: 119–130.
6. White, M. 1999. Mediators of inflammation and the inflammatory process. Journal of Allergy and Clinical Immunology 103: S378–S381.
7. Yadav, S.K., B. Adhikary, S. Chand, B. Maity, S.K. Bandyopadhyay, and S. Chattopadhyay. 2012. Molecular mechanism of indomethacin-induced gastropathy. Free Radical Biology and Medicine 52: 1175–1187.
8. Natarajan, S.K., A. Mukhopadhya, A. Ramachandran, S. Amalanathan, G. Kurian, and K.A. Balasubramanian. 2007. Spontaneous bacterial peritonitis results in oxidative and nitrosative stress in ascitic fluid. Journal of Gastroenterology and Hepatology 22: 177–181.
9. Sautebin, L. 2000. Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy. Fitoterapia 71: S48–S57.
10. Moeller, B., and P.M. Villiger. 2006. Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases. Springer Seminars in Immunopathology 27: 391–408.
11. Xie, W.L., J.G. Chipman, D.L. Robertson, R.L. Erikson, and D.L. Simmons. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proceedings of the National Academy of Sciences 88: 2692–2696.
12. Abdel-Aziz, A.A.M., K.E.H., ElTahir, and Y.A. 2011. Asiri synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study. European Journal of Medicinal Chemistry 46: 1648–1655.
13. Soll, A.H., and D. McCarthy. 1999. NSAID-related gastrointestinal complications. Clinical Cornerstone 1(5): 42–56.
14. Niu, X., W. Li, H. Xu, X. Liu, and L. Qi. 2013. Simultaneous quantification of 11 isoquinoline alkaloids in Corydalis impatiens (Pall.) Fisch by HPLC. Journal of Separation Science 36: 2090–2095.
15. Niu, X.F., H.B. Xu, X. Liu, T. Fan, and L. Qi. 2013. Isoquinoline alkaloids from Corydalis impatiens. Chemistry of Natural Compounds 49: 187–189.
16. Hosseinzadeh, H., M.H. Haddadkhodaparast, and A.R. Arash. 2003. Antinociceptive, antiinflammatory and acute toxicity effects of Salvia leriifolia Benth. seed extract in mice and rats. Phytotherapy Researc 17: 422–425.
17. Cho, J.Y., K.U. Baik, J.H. Jung, and M.H. Park. 2000. In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. European Journal of Pharmacology 398: 399–407.
18. Feng, W.G., Y.B. Wang, J.S. Zhang, and C.L. Li. 2002. cAMP elevators inhibit LPS-induced IL-12 p40 expression by interfering with phosphorylation of p38 MAPK in murine peritoneal macrophages. Cell Research 12: 331–337.
19. Pauwels, R., J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, and E. De Clercq. 1988. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of virological method 20: 309–321.
20. Chibli, L.A., K. Rodrigues, C.M. Gasparetto, N.C. Pinto, R.L. Fabri, E. Scio, and O.V. Sousa. 2014. Anti-inflammatory effects of Bryophyllum pinnatum (Lam.) Oken ethanol extract in acute and chronic cutaneous inflammation. Journal of Ethnopharmacology 154: 330–338.
21. Carlson, R.P., J. Chang, and A.J. Lewis. 1985. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents and Actions 17: 197–204.
22. Niu, X., T. Fan, W. Li, W. Xing, and H. Huang. 2012. The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages. European Journal of Pharmacology 689: 262–269.
23. Banerjee, S., T.K. Sur, S. Mandal, P.C. Das, and S. Sikdar. 2000. Assessment of the anti-inflammatory effects of Swertia chirata in acute and chronic experimental models in male albino rats. Indian Journal of Pharmacology 32: 21–24.
24. Clementi, G., A. Caruso, V.M.C. Cutuli, A. Prato, N.G. Mangano, and M. Amico-Roxas. 1999. Antiinflammatory activity of adrenomedullin in the acetic acid peritonitis in rats. Life Sciences 65: PL203–PL208.
25. St-Onge, M., N. Flamand, J. Biarc, S. Picard, L. Bouchard, A.A. Dussault, C. Laflamme, M.J. James, G.E. Caughey, L.G. Cleland, P. Borgeat, and M. Pouliot. 2007. Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils. Biochimica et Biophysica Acta 1771: 1235–1245.
26. Ribeiro, R.A., M.L. Vale, S.M. Thomazzi, A.B. Paschoalato, S. Poole, S.H. Ferreira, and F.Q. Cunha. 2000. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. European Journal of Pharmacology 387: 111–118.
27. Yun, K.J., J.Y. Kim, J.B. Kim, K.W. Lee, S.Y. Jeong, H.J. Park, and K.T. Lee. 2008. Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways. International Immunopharmacology 8: 431–441.
28. Yoon, H.J., M.E. Moon, H.S. Park, H.W. Kim, S.Y. Im, J.H. Lee, and Y.H. Kim. 2008. Effects of chitosan oligosaccharide (COS) on the glycerol-induced acute renal failure in vitro and in vivo. Food and Chemical Toxicology 46: 710–716.
29. Moncada, S., R.M.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43: 109–142.
30. Nagai, H., H. Kumamoto, M. Fukuda, and T. Takahashi. 2003. Inducible nitric oxide synthase and apoptosis-related factors in the synovial tissues of temporomandibular joints with internal derangement and osteoarthritis. Journal of Oral and Maxillofacial Surgery 61: 801–807.
31. Dinarello, C.A. 1997. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112: 321S–329S.
32. Fehsel, K., K.D. Kröncke, K.L. Meyer, H. Huber, V. Wahn, and V. Kolb-Bachofen. 1995. Nitric oxide induces apoptosis in mouse thymocytes. The Journal of Immunology 155: 2858–2865.
33. Hong, S.K., H.J. Kim, C.S. Song, I.S. Choi, J.B. Lee, and S.Y. Park. 2012. Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice. International Immunopharmacology 13: 23–27.
34. Subbaramaiah, K., N. Telang, J.T. Ramonetti, R. Araki, B. DeVito, B.B. Weksler, and A.J. Dannenberg. 1996. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Research 56: 4424–4429.
35. Utar, Z., M.A. Majid, M.I. Adenan, M.F. Jamil, and T.M. Lan. 2011. Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW264.7 macrophage cells. Journal of Ethnopharmacology 136: 75–82.